Only few studies have reported on the use of OPCAB technique for redo coronary surgery [1, 6, 16–19]. The largest report in 617 patients from Japan focuses on in-hospital outcome only with no late survival and suggests that redo-OPCAB surgery is associated with lower 30 days mortality (3.5 vs 7%) and less complications (11 vs 21.5%) compared to redo-CABG [1]. Other studies from North America and India have reported on redo-OPCAB, although in small cohorts [1, 7, 17, 18, 20, 21].